Navigation Links
Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy
Date:7/16/2013

MILWAUKEE, July 16, 2013 /PRNewswire/ -- Elekta (NSE: EKTAb) and Royal Philips (NYSE: PHG, AEX: PHIA) announced today that the Froedtert & The Medical College of Wisconsin Clinical Cancer Center (Milwaukee, Wisconsin) will join a consortium that is investigating the development of a magnetic resonance imaging (MRI) guided radiation therapy system.

"The Froedtert & Medical College of Wisconsin Clinical Cancer Center is an exceptional addition to the consortium," says Tomas Puusepp, Elekta President and CEO. "It is a nationally renowned cancer research institute, boasts in-depth expertise in every kind of cancer, is staffed by fully coordinated specialist teams and uses the latest innovative therapies and technologies."

The Froedtert & Medical College of Wisconsin Clinical Cancer Center is the fifth member to sign the research agreement to evaluate the new technology, which unites radiation therapy and MRI in a single system. Current clinical members of the group include the University Medical Center Utrecht (Utrecht, the Netherlands), The University of Texas MD Anderson Cancer Center (Houston, Texas), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam, the Netherlands) and Sunnybrook Health Sciences Centre (Toronto, Ontario).

Integrating an advanced 1.5 Tesla MRI machine with a sophisticated adaptive radiation therapy system will provide physicians with depictions of a patient's soft tissues and tumor and allow them to dynamically track their motion. This innovation is designed to enable clinicians to deliver radiation under real-time MR guidance.

"We are eager to join this consortium of leading institutions. The research and clinical faculty of our canc
'/>"/>

SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
3. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
4. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
5. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
8. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
9. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
10. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
11. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015 The Coalition of State ... and regional professional rheumatology societies, today released the ... explored perceptions of biosimilars and the potential impact ... Biosimilars are medicines that are highly similar, ... notably different from generic medications in that it ...
(Date:7/1/2015)... N.J. , July 1, 2015 ContraVir ... focused on the development and commercialization of targeted antiviral ... Cantor Fitzgerald Inaugural Healthcare Conference taking place in ... 2015 at Le Parker Meridien Hotel. ... an overview of the Company,s business during his live ...
(Date:7/1/2015)... , July 1, 2015 Eli Lilly and Company ... the second quarter of 2015 on Thursday, July 23, 2015. ... with the investment community and media to further detail the ... at 9 a.m. EDT. Investors, media and the general public ... a link that will be posted on Lilly,s website at ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2
... AUSTIN, Texas, June 27, 2011 Luminex Corporation (NASDAQ: ... its acquisition of privately-held EraGen Biosciences, Inc., an innovator ... genetic applications, for $34 million in cash. ... EraGen acquisition will add between $5 million and $7 ...
... ChemoCentryx, Inc. today announced that the Company,s novel ... in experimental models.  These data implicate CCR2-driven processes ... associated complications such as diabetic nephropathy.  Results were ... Improves Renal Function and Hyperglycemia in Preclinical Models ...
Cached Medicine Technology:Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc. 2Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc. 3ChemoCentryx Reports Novel CCR2 Antagonist Significantly Improves Kidney Function and Hyperglycemia in Models of Type 2 Diabetes 2ChemoCentryx Reports Novel CCR2 Antagonist Significantly Improves Kidney Function and Hyperglycemia in Models of Type 2 Diabetes 3
(Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, the leader ... announced the release and publication of their newest offering to complement the existing ... Newsletter. , Designed in support of coverage for the full spectrum of ...
(Date:7/2/2015)... ... July 02, 2015 , ... Maddock Douglas is ... and business models. To help manage the increasing demand for innovation as a ... as SVP of Strategic Engagements. , Benkendorf is a seasoned management executive with ...
(Date:7/1/2015)... ... 01, 2015 , ... In the United States, summer has always been the ... Saudi Arabia and Dubai, the summer temperatures are so hot, that July vacationers often ... Sam Saleh of ORA Dentistry Spa notes that a trip to the United States, ...
(Date:7/1/2015)... ... 01, 2015 , ... Dr. Jian-Dong Li, a professor and ... Georgia Research Alliance Eminent Scholar in Inflammation and Immunity, has received a five-year, ... The grant from the National Institute on Deafness and Other Communication Disorders of ...
(Date:7/1/2015)... ... July 01, 2015 , ... The federal court ... http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion for Summary Judgment. According to an ... June 26th, the Court rejected the Plaintiff’s assertion that one manufacturer can ...
Breaking Medicine News(10 mins):Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, ... Ellie, was diagnosed with a severe peanut allergy, the New ... and never leaves home without it. The device contains ... even life-threatening allergic reactions. But it,s not only Able ...
... , THURSDAY, Feb. 9 (HealthDay News) -- The number ... to engage in regular exercise has increased steadily over ... health officials. The U.S. Centers for Disease Control ... more Americans lower their risk for chronic illnesses, reduce ...
... Feb. 9, 2012 Wake Forest Baptist Medical Center ... into tumors and heating them with a quick, 30-second laser ... effort involving kidney tumors was published in 2009, but now ... tumors, specifically the tumor initiating cancer stem cells. These stem ...
... and under-studied subset of diseases affecting the lymphatic system ... disease is the focus of a special issue of ... published by Mary Ann Liebert, Inc. . The ... Guest Editor, and Journal Associate Editor Francine ...
... certain cancer cells may exhibit greater flexibility than normal ... tumor growth. Now computer simulations developed by Boston University ... the University of Texas at Austin appear to support ... cells that they,ve created indicates that the softening of ...
... 9 (HealthDay News) -- ,The longer Hispanic women live in the ... birth, a new study says. Researchers analyzed data from 2,141 ... the U.S. National Health and Nutrition Examination Survey 1999-2006. The ... for women who had lived in the United States for less ...
Cached Medicine News:Health News:More People Need Training in Lifesaving Epinephrine Use, Advocates Say 2Health News:More People Need Training in Lifesaving Epinephrine Use, Advocates Say 3Health News:More U.S. Doctors Are Urging Patients to Exercise: CDC 2Health News:Nanotube therapy takes aim at breast cancer stem cells 2Health News:Boston University research suggests new pathways for cancer progression 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: